Neoadjuvant therapy
refers to a therapy that is given before the primary
treatment in the hopes of making the treatment more
effective. In the case of prostate, neoadjuvant hormone
therapy, is commonly given to patients with enlarged
prostate glands in order to decrease the organ’s
volume. Prostate cancer treatments are generally most
effective to those with small prostate glands. A large
prostate gland may cause complications during the prostatectomy
or cause the surrounding organs to be damaged during
external beam radiation therapy. An enlarged gland could
also cause the prostate to be ineffectively treated
during cryotherapy or brachytherapy.
|
